Breaking News Instant updates and real-time market news.

WRD

WildHorse Resource

06:54
11/06/18
11/06
06:54
11/06/18
06:54

WildHorse Resource downgraded to Outperform from Strong Buy at Raymond James

  • 08

    Nov

  • 26

    Nov

WRD WildHorse Resource

11/01/18
RAJA
11/01/18
UPGRADE
RAJA
Outperform
WildHorse Resource upgraded to Outperform from Market Perform at Raymond James
10/31/18
SUSQ
10/31/18
UPGRADE
Target $5
SUSQ
Positive
Chesapeake upgraded to Positive after WildHorse deal at Susquehanna
As reported previously, Susquehanna analyst Biju Perincheril upgraded Chesapeake (CHK) to Positive from Neutral following its deal to acquire WildHorse Resource (WRD). The analyst said his upgrade is based on now visible and material oil-weighted growth, with a line-of-sight to free cash flow generation after 2019. He believes operational improvements will put the company on a path toward sustainable organic balance sheet deleveraging. Perincheril has a $5 price target on Chesapeake shares.
10/31/18
IMPC
10/31/18
NO CHANGE
Target $5
IMPC
In-Line
Chesapeake price target lowered to $5 from $6 at Imperial Capital
Imperial Capital analyst Jason Wangler lowered his price target for Chesapeake Energy (CHK) to $5 from $6 following the company's Q3 results and announcement of a definitive agreement to acquire WildHorse Resource Development (WRD). The acquisition should add to Chesapeake's oil inventory and improve balance sheet metrics, and "multiple synergies" should provide additional benefits in the transaction, Wangler tells investors in a research note. The analyst keeps an In-Line rating on Chesapeake shares.
08/09/18
08/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ormat Technologies (ORA) upgraded to Overweight from Neutral at JPMorgan by analyst Paul Coster. The company reported mixed Q2 results and guidance owing to disruption at the Puna plant in Hawaii, but Coster believes that when excluding Puna, Ormat's execution "remains solid" and the company's long-term growth prospects "remain undimmed." 2. Wright Medical (WMGI) upgraded to Buy from Neutral at BofA/Merrill by analyst Travis Steed, who cited increased confidence in 2H 2018 and 2019 double digit growth and upside to Street estimates. Steed said growth in the core lower extremities business returned to market rates for the first time since Q1 2016 and believes it can accelerate further from new products and productivity ramps. 3. WildHorse Resource (WRD) upgraded to Buy from Hold at SunTrust by analyst Welles Fitzpatrick, who noted that the 13% decline in the stock price "makes little sense" from differentials or CapEx point of view, adding that the move in pricing does not warrant the large decline. Fitzpatrick views WildHorse Resource as a "simple, single-basin story, with distinct, quantifiable advantages such as premium oil pricing given its gulf coast access, ability to realized material savings with an in-field sand mine, and optionality to expand its midstream system." 4. ITG (ITG) upgraded to Overweight from Neutral at JPMorgan by analyst Kenneth Worthington, saying that the company's fundamentals are improving as it gains "traction on a number of fronts" that have and will continue to drive higher earnings power over time, particularly outside the U.S. 5. Comstock Resources (CRK) upgraded to Buy from Neutral at Ladenburg by analyst Michael Schmitz, who said the recent pullback in shares provides an attractive entry point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

OI

Owens-Illinois

$16.76

0.55 (3.39%)

06:52
11/14/18
11/14
06:52
11/14/18
06:52
Hot Stocks
Owens-Illinois initiates dividend of 5c, raises share repurchase to $600M »

The company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

PENN

Penn National

$19.76

-0.3 (-1.50%)

06:52
11/14/18
11/14
06:52
11/14/18
06:52
Recommendations
Penn National analyst commentary  »

Penn National added to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$16.82

-0.08 (-0.47%)

06:51
11/14/18
11/14
06:51
11/14/18
06:51
Earnings
Meritor sees FY19 adj. EPS about $3.10, consensus $3.32 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 06

    Dec

  • 13

    Dec

LLY

Eli Lilly

$111.85

-0.77 (-0.68%)

06:51
11/14/18
11/14
06:51
11/14/18
06:51
Hot Stocks
Eli Lilly submits NDA for lasmiditan, gets breakthrough designation for Emgality »

Eli Lilly has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

06:50
11/14/18
11/14
06:50
11/14/18
06:50
General news
European stock markets pared some of their losses »

European stock markets…

GOOS

Canada Goose

$58.60

1.51 (2.64%)

06:49
11/14/18
11/14
06:49
11/14/18
06:49
Earnings
Canada Goose raises FY19 adj. EPS growth view to at least 25% from at least 40% »

Consensus for FY19 EPS is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

SGMO

Sangamo

$10.80

0.8 (8.00%)

, BMRN

BioMarin

$93.51

0.43 (0.46%)

06:49
11/14/18
11/14
06:49
11/14/18
06:49
Downgrade
Sangamo, BioMarin, Spark Therapeutics rating change  »

JPMorgan downgrades…

SGMO

Sangamo

$10.80

0.8 (8.00%)

BMRN

BioMarin

$93.51

0.43 (0.46%)

ONCE

Spark Therapeutics

$42.74

1.12 (2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MTOR

Meritor

$16.82

-0.08 (-0.47%)

06:49
11/14/18
11/14
06:49
11/14/18
06:49
Earnings
Meritor reports Q4 adj. EPS 82c, consensus 71c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 06

    Dec

  • 13

    Dec

MRK

Merck

$74.62

-0.06 (-0.08%)

06:48
11/14/18
11/14
06:48
11/14/18
06:48
Hot Stocks
Merck: Phase 3 KEYNOTE-181 trial met a primary endpoint of overall survival »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 11

    Jan

  • 16

    Feb

WFC

Wells Fargo

$52.74

0.38 (0.73%)

06:47
11/14/18
11/14
06:47
11/14/18
06:47
Periodicals
Departure of top Wells Fargo exec Hardison shows rift with regulator, WSJ says »

Hope Hardison, Wells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

TRU

TransUnion

$64.43

-0.41 (-0.63%)

06:47
11/14/18
11/14
06:47
11/14/18
06:47
Hot Stocks
TransUnion CEO James Peck to retire, Chris Cartwright to succeed »

TransUnion announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$58.60

1.51 (2.64%)

06:46
11/14/18
11/14
06:46
11/14/18
06:46
Earnings
Canada Goose reports Q2 adjusted EPS 46c, consensus (7c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

K

Kellogg

$63.48

-0.81 (-1.26%)

, GIS

General Mills

$45.50

-0.2 (-0.44%)

06:46
11/14/18
11/14
06:46
11/14/18
06:46
Downgrade
Kellogg, General Mills, Kraft Heinz rating change  »

JPMorgan downgrades…

K

Kellogg

$63.48

-0.81 (-1.26%)

GIS

General Mills

$45.50

-0.2 (-0.44%)

KHC

Kraft Heinz

$53.38

-0.29 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

06:45
11/14/18
11/14
06:45
11/14/18
06:45
General news
Breaking General news story  »

Week of 11/9 MBA Mortgage…

JNCE

Jounce Therapeutics

$4.40

-0.06 (-1.35%)

06:40
11/14/18
11/14
06:40
11/14/18
06:40
Downgrade
Jounce Therapeutics rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,631.68

-5.02 (-0.31%)

06:38
11/14/18
11/14
06:38
11/14/18
06:38
Periodicals
Amazon says over 10,000 workers are developing Alexa, Echo, WSJ reports »

Amazon has over 10,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

NOVN

Novan

$2.50

-0.04 (-1.57%)

06:38
11/14/18
11/14
06:38
11/14/18
06:38
Hot Stocks
Novan Phase 2 molluscum contagiosum trial achieves statistical significance »

Novan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

LLESY

Lendlease Group

$0.00

(0.00%)

06:37
11/14/18
11/14
06:37
11/14/18
06:37
Upgrade
Lendlease Group rating change  »

Lendlease Group upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICI

VICI Properties

$21.47

-0.03 (-0.14%)

06:36
11/14/18
11/14
06:36
11/14/18
06:36
Syndicate
VICI Properties files to sell 25M shares of common stock »

Goldman Sachs & Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLI

Hollysys

$18.58

-0.37 (-1.95%)

06:36
11/14/18
11/14
06:36
11/14/18
06:36
Earnings
Hollysys reports Q1 adjusted EPS 46c vs. 36c last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ATRO

Astronics

$28.50

-0.13 (-0.45%)

06:35
11/14/18
11/14
06:35
11/14/18
06:35
Earnings
Astronics sees FY19 Aerospace revenue $710M-$745M »

"In our third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

HOLI

Hollysys

$18.58

-0.37 (-1.95%)

06:35
11/14/18
11/14
06:35
11/14/18
06:35
Upgrade
Hollysys rating change  »

Hollysys upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

, GOOGL

Alphabet Class A

$1,048.54

-1.06 (-0.10%)

06:34
11/14/18
11/14
06:34
11/14/18
06:34
Periodicals
Google to double New York City staff over next ten years, WSJ reports »

Google (GOOGL) has plans…

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

GOOGL

Alphabet Class A

$1,048.54

-1.06 (-0.10%)

AMZN

Amazon.com

$1,631.68

-5.02 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

ZYME

Zymeworks

$13.04

-0.2 (-1.51%)

06:33
11/14/18
11/14
06:33
11/14/18
06:33
Hot Stocks
Zymeworks updates clinical data for ZW25 anti-tumor candidate »

Zymeworks presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRO

Astronics

$28.50

-0.13 (-0.45%)

06:33
11/14/18
11/14
06:33
11/14/18
06:33
Hot Stocks
Astronics sells semiconductor test business to Advantest for $185M in cash »

Astronics announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.